BMJ Confidential: For Review Only Opening the blinds and shedding light on the risks and problems of blinding in clinical trials Journal: BMJ Manuscript ID BMJ-2019-050313 Article Type: Analysis BMJ Journal: BMJ Date Submitted by the 18-Apr-2019 Author: Complete List of Authors: Anand, Rohan; Queen's University Belfast, Wellcome-Wolfson Institute for Experimental Medicine Norrie, John; University of Edinburgh, Usher Institute of Population Health Sciences and Informatics Bradley, Judy; Queen's University Belfast, Wellcome-Wolfson Institute for Experimental Medicine McAuley, Daniel; Queen's University Belfast, Wellcome-Wolfson Institute for Experimental Medicine Clarke, Mike; Queen's University Belfast, Northern Ireland Methodology Hub blinding, placebos, clinical trials, pragmatic trials, clinical trial Keywords: methodology, RCT, PROBE, bias https://mc.manuscriptcentral.com/bmj Page 1 of 25 BMJ 1 2 3 1 Full Title: 4 5 6 7 2 Opening the blinds and shedding light on the risks and problems of blinding 8 9 3 10 in clinical trials 11 12 Confidential: For Review Only 13 4 Standfast: Blinding can have negative implications for a clinical trial. 14 15 16 5 Author Positions, Names and Emails: 17 18 19 6 Rohan Anand1,
[email protected], (ORCiD: 0000-0002-1957-5336); 20 21 7 Professor John Norrie2,
[email protected], 22 23 24 8 Professor Judy M Bradley3,
[email protected], (ORCiD: 0000-0002-7423-135X) 25 26 9 Professor Danny F McAuley4,
[email protected], (ORCiD: 0000-0002-3283-1947) 27 28 29 10 Professor Mike Clarke5,
[email protected], (ORCiD: 0000-0002-2926-7257) 30 31 11 32 33 34 12 Author Affiliations and Addresses: 35 36 13 1 Doctoral Research Student in Clinical Trial Methodology; Wellcome-Wolfson Institute for 37 38 39 14 Experimental Medicine; School of Medicine, Dentistry and Biomedical Sciences; Queen's 40 41 15 University Belfast; Belfast; BT9 7BL; United Kingdom.